Jordan Registration Fees Breakdown: Official Charges Including the 700 JOD Circulation Study Fee

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

The official fees of the JFDA in Jordan are structured per item rather than as a single flat price per product. GRZAN has consolidated the nine core fees: circulation (registration) study 700 JOD, technical committee study 100 JOD, import invoice approval 10 JOD, batch testing / circulation 125 JOD, site approval 700 JOD, GLP certificate issuance / renewal / scope extension 1,000 JOD, objection application 100 JOD, variation study 25 JOD, and certificate issuance 20 JOD.

  • Second conclusion: the direct government fees for documentation are at a relatively low level within the Middle East region. On the most common combination, the main official fees for one registration are the circulation study at 700 JOD plus certificate issuance at 20 JOD, totalling 720 JOD (excluding testing, site approval and variations). The low headline figure should not, however, be read as the whole cost.
  • Third conclusion: official fees are only a small fraction of the total cost. The indirect costs of translation, notarisation, consular legalisation, sample delivery and local testing usually significantly exceed the official fees themselves (practical estimate). The indirect side of the budget therefore deserves as much attention as the fee schedule itself.

2. Legal basis

The fee obligations for registration and importation rest on the following instruments.

RegulationReference / numberPublication dateProvision / relevance
JFDA fee scheduleJFDA official fee itemsCurrent version in forceCirculation (registration) study 700 JOD; technical committee study 100 JOD; import invoice approval 10 JOD; batch testing / circulation 125 JOD; site approval 700 JOD; GLP certificate 1,000 JOD; objection 100 JOD; variation study 25 JOD; certificate issuance 20 JOD
Medical Devices Importation Directives (including sterilizers and detergents)Medical Devices Importation Directives Including Sterilizers & DetergentsCurrent version in forcePayment and application clauses (the applicant shall pay the required fees)
Registration Guidelines for Medical DevicesRegistration Guidelines for Medical Devices2017Fee-related procedural clauses

The amounts are the official fees listed in the JFDA fee schedule; clause numbers must be verified against the Arabic originals of the Official Gazette of Jordan.

3. Expert insights

Insight 1: the granularity of the fee items reflects the staged nature of the process. The nine fees correspond respectively to registration review (700 JOD), technical committee deliberation (100 JOD), certificate issuance (20 JOD), variations (25 JOD), objections (100 JOD), import (10 JOD), batch testing (125 JOD), site approval (700 JOD) and GLP certification (1,000 JOD). This structure allows a company to estimate its costs stage by stage. For budgeting purposes, the nine items can be grouped into one-off registration costs, per-batch circulation costs and conditional costs.

Insight 2: payment takes place before submission. The importation directives state that the applicant shall pay the required fees, after which the application form is completed and the documents submitted. Where the fees have not been settled, no valid acceptance of the application arises. In practice, this means the payment arrangements should be confirmed with the AR before the dossier is finalised.

Insight 3: batch testing and site approval are variable costs. Batch testing at 125 JOD arises per batch, and site approval at 700 JOD arises per occurrence. Whether either of the two is triggered depends on the product and on the reviewer’s judgement, which makes them the parts of the budget with the highest uncertainty. A budget built only on the base fees therefore understates the realistic range of total cost.

Insight 4: the 1,000 JOD GLP certificate points to laboratory-related qualifications. This item does not usually apply to ordinary device registration, but it appears where laboratory capability or specific testing qualifications are involved. Companies should plan on a may-not-trigger basis while retaining budget flexibility. Treating it as conditional keeps the registration budget honest without inflating it.

Insight 5: exchange rate conversion affects budget precision. Industry material puts 1 JOD at approximately 1.41 US dollars (practical estimate). When preparing cross-border budgets, companies should fix a single exchange rate baseline and record the baseline date, so that currency fluctuations do not distort the budget. The same baseline should then be applied consistently across every budget line, so that the conversion remains coherent.

4. Practical recommendations

  • Prepare the budget by item rather than by product. Split the nine fees apart and assess the trigger probability and the expected number of occurrences for each item individually. This turns a single opaque total into a set of decidable decisions.
  • Reserve flexibility for batch testing and site approval. These two items are the parts of the budget most likely to exceed the base amount. A percentage buffer on the base budget is the simplest way to hold this flexibility.
  • List the indirect costs on a separate line. Translation, notarisation, consular legalisation (4 to 6 weeks, practical estimate), sample delivery and local testing usually cost more than the official fees. These items should be quoted and booked before the registration starts, not absorbed later.
  • Confirm the version of the fee schedule before submission. The JFDA fee schedule may be adjusted; verify the current version through the AR before filing.

5. Verification checklist

  • □ Confirm the current version of the JFDA fee schedule and the amounts of the nine fees
  • □ Budget by item, assessing trigger probability and number of occurrences for each
  • □ Reserve flexibility for batch testing (125 JOD) and site approval (700 JOD)
  • □ List translation, notarisation, consular legalisation, sample delivery and local testing costs separately
  • □ Fix an exchange rate baseline and record the baseline date (practical estimate of about 1 JOD ≈ 1.41 US dollars)
  • □ Confirm that the fees have been settled in full before submission
  • □ Re-verify the cited clause numbers against the Arabic originals of the Official Gazette

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Jordanian market. Our team coordinates local importer arrangements, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail